NCT03665090

Brief Summary

To describe the design, methodology and baseline characteristics of the Shanghai Cohort study of Diabetic Eye disease (SCODE) study, a community-based study to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

August 30, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 11, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

September 11, 2018

Status Verified

September 1, 2018

Enrollment Period

3 years

First QC Date

August 30, 2018

Last Update Submit

September 6, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence and incidence rate of diabetic eye disease

    SCODE was performed to evaluate the prevalence and rate of new cases of diabetic eye disease, especially DR, in a three-year community-based cohort study for the people with diabetes, and to identify the associated factors related with diabetic eye disease.

    December 31, 2018

Secondary Outcomes (6)

  • Grading of DR

    December 31, 2018

  • Retinal and choroidal thickness

    December 31, 2018

  • Retinal blood flow

    December 31, 2018

  • Blood biochemistry indexes

    December 31, 2018

  • Urine biochemistry indexes

    December 31, 2018

  • +1 more secondary outcomes

Interventions

Community-based, prospective cohort study from three consecutive years (2016 to 2018) to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All the enrolled participants got a yearly examination of diabetic eye disease for three years. Considering that the prevalence of DR gradually increases with age, the target population included adults with diabetes aged 35 years and above under archives management, residing in Shanghai. And the study participants were expected to be freely mobile, clear-thinking, and capable of cooperating to complete the ophthalmic examinations.

You may qualify if:

  • Adults with diabetes aged 35 years and above; under archives management; residing in Shanghai.

You may not qualify if:

  • All the study participants have difficulties of mobility or communication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Xiang Z, Lin S, Xu Y, Lu L, Shi Y, Wang Y, Yang Q, Ling S, Zhou D, Qin X, Cheng M, Zou H, Ma Y. The effects of physical activity on diabetic retinopathy in type 2 diabetes using automated vascular analysis: a cohort study. J Glob Health. 2025 Dec 5;15:04319. doi: 10.7189/jogh.15.04319.

Biospecimen

Retention: SAMPLES WITH DNA

Urine and Blood Sample Collection

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 30, 2018

First Posted

September 11, 2018

Study Start

January 1, 2016

Primary Completion

December 31, 2018

Study Completion

December 31, 2020

Last Updated

September 11, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will share

Identified individual participant data for all primary and secondary outcome measures will be made available.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data will be available with in one year of study completion.
Access Criteria
Data access requests will be reviewed by an external Independent Review Panel. Requestors will be required to sign a Data Access Agreement.